BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 28756053)

  • 1. Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis Frequently Have Subclinical Inflammation in the Proximal Colon.
    Krugliak Cleveland N; Rubin DT; Hart J; Weber CR; Meckel K; Tran AL; Aelvoet AS; Pan I; Gonsalves A; Gaetano JN; Williams KM; Wroblewski K; Jabri B; Pekow J
    Clin Gastroenterol Hepatol; 2018 Jan; 16(1):68-74. PubMed ID: 28756053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Symptoms Do Not Correlate With Findings From Colonoscopy in Children With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis.
    Ricciuto A; Fish J; Carman N; Walters TD; Church PC; Hansen BE; Crowley E; Siddiqui I; Nguyen GC; Kamath BM; Griffiths AM
    Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1098-1105.e1. PubMed ID: 29378308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathologic features of ulcerative colitis in patients with primary sclerosing cholangitis: a case-control study.
    Joo M; Abreu-e-Lima P; Farraye F; Smith T; Swaroop P; Gardner L; Lauwers GY; Odze RD
    Am J Surg Pathol; 2009 Jun; 33(6):854-62. PubMed ID: 19295408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease.
    Boonstra K; van Erpecum KJ; van Nieuwkerk KM; Drenth JP; Poen AC; Witteman BJ; Tuynman HA; Beuers U; Ponsioen CY
    Inflamm Bowel Dis; 2012 Dec; 18(12):2270-6. PubMed ID: 22407885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duration and severity of primary sclerosing cholangitis is not associated with risk of neoplastic changes in the colon in patients with ulcerative colitis.
    Navaneethan U; Kochhar G; Venkatesh PG; Lewis B; Lashner BA; Remzi FH; Shen B; Kiran RP
    Gastrointest Endosc; 2012 May; 75(5):1045-1054.e1. PubMed ID: 22405258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Random biopsies during surveillance colonoscopy increase dysplasia detection in patients with primary sclerosing cholangitis and ulcerative colitis.
    Navaneethan U; Kochhar G; Venkatesh PG; Bennett AE; Rizk M; Shen B; Kiran RP
    J Crohns Colitis; 2013 Dec; 7(12):974-81. PubMed ID: 23523416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural history of low grade dysplasia in patients with primary sclerosing cholangitis and ulcerative colitis.
    Venkatesh PG; Jegadeesan R; Gutierrez NG; Sanaka MR; Navaneethan U
    J Crohns Colitis; 2013 Dec; 7(12):968-73. PubMed ID: 23433613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High Serum sCD40 and a Distinct Colonic T Cell Profile in Ulcerative Colitis Associated With Primary Sclerosing Cholangitis.
    Lampinen M; Vessby J; Fredricsson A; Wanders A; Rorsman F; Carlson M
    J Crohns Colitis; 2019 Mar; 13(3):341-350. PubMed ID: 30383225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unique Phenotypic Characteristics and Clinical Course in Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis: A Multicenter US Experience.
    Wang MH; Mousa OY; Friton JJ; Raffals LE; Leighton JA; Pasha SF; Picco MF; Cushing KC; Monroe K; Nix BD; Newberry RD; Faubion WA
    Inflamm Bowel Dis; 2020 Apr; 26(5):774-779. PubMed ID: 31626701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis.
    Brentnall TA; Haggitt RC; Rabinovitch PS; Kimmey MB; Bronner MP; Levine DS; Kowdley KV; Stevens AC; Crispin DA; Emond M; Rubin CE
    Gastroenterology; 1996 Feb; 110(2):331-8. PubMed ID: 8566577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of ulcerative colitis on the long-term outcome of patients with primary sclerosing cholangitis.
    Navaneethan U; Venkatesh PG; Lashner BA; Shen B; Kiran RP
    Aliment Pharmacol Ther; 2012 May; 35(9):1045-53. PubMed ID: 22428605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histologic markers of inflammation in patients with ulcerative colitis in clinical remission.
    Rosenberg L; Nanda KS; Zenlea T; Gifford A; Lawlor GO; Falchuk KR; Wolf JL; Cheifetz AS; Goldsmith JD; Moss AC
    Clin Gastroenterol Hepatol; 2013 Aug; 11(8):991-6. PubMed ID: 23591275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis and the risk of developing malignancies. A large prospective study.
    Terg R; Sambuelli A; Coronel E; Mazzuco J; Cartier M; Negreira S; Muñoz A; Gil A; Miguez C; Huernos S; Romero G; Goncalvez S; Levi D; Abecasis R
    Acta Gastroenterol Latinoam; 2008 Mar; 38(1):26-33. PubMed ID: 18533354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [CLINICAL AND MORPHOLOGICAL CHARACTERISTICS OF INTESTINAL LESIONS IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS].
    Pazenco EV; Karev VE; Raikhelson KL; Shchukina OB; Botina AV; Kharitonov AG; Semenov NV
    Eksp Klin Gastroenterol; 2016; (7):18-24. PubMed ID: 30284417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential.
    Broomé U; Löfberg R; Veress B; Eriksson LS
    Hepatology; 1995 Nov; 22(5):1404-8. PubMed ID: 7590655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Natural History of Newly Diagnosed Ulcerative Colitis in Patients with Concomitant Primary Sclerosing Cholangitis.
    Khan N; Trivedi C; Shah Y; Cole E; Lewis J; Yang YX
    Inflamm Bowel Dis; 2018 Aug; 24(9):2062-2067. PubMed ID: 29697792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulated eosinophil activity in ulcerative colitis with concomitant primary sclerosing cholangitis.
    Lampinen M; Fredricsson A; Vessby J; Martinez JF; Wanders A; Rorsman F; Carlson M
    J Leukoc Biol; 2018 Jul; 104(1):173-183. PubMed ID: 29603385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low Fecal Calprotectin Correlates with Histological Remission and Mucosal Healing in Ulcerative Colitis and Colonic Crohn's Disease.
    Zittan E; Kelly OB; Kirsch R; Milgrom R; Burns J; Nguyen GC; Croitoru K; Van Assche G; Silverberg MS; Steinhart AH
    Inflamm Bowel Dis; 2016 Mar; 22(3):623-30. PubMed ID: 26829408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The fate of indefinite and low-grade dysplasia in ulcerative colitis and primary sclerosing cholangitis colitis before and after liver transplantation.
    Eaton JE; Smyrk TC; Imam M; Pardi DS; Loftus EV; Owens VL; Talwalkar JA
    Aliment Pharmacol Ther; 2013 Oct; 38(8):977-87. PubMed ID: 24033551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Th1 and Innate Lymphoid Cells Accumulate in Primary Sclerosing Cholangitis-associated Inflammatory Bowel Disease.
    Gwela A; Siddhanathi P; Chapman RW; Travis S; Powrie F; Arancibia-Cárcamo CV; Geremia A
    J Crohns Colitis; 2017 Sep; 11(9):1124-1134. PubMed ID: 28383652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.